Dual opioid analgesia

[1]  K. Perreault,et al.  The Revised IASP Definition of Pain and Accompanying Notes: Considerations for the Physiotherapy Profession. , 2021, Physiotherapy Canada. Physiotherapie Canada.

[2]  Cynthia Wright Talton.  Serotonin Syndrome/Serotonin Toxicity. , 2020, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

[3]  H. Ding,et al.  Nociceptin/orphanin FQ peptide receptor-related ligands as novel analgesics. , 2020, Current topics in medicinal chemistry.

[4]  J. Fudin,et al.  A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain , 2020, Pain and Therapy.

[5]  K. Karamchandani,et al.  The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice , 2019, International journal of molecular sciences.

[6]  Shao-Cheng Wang.  Historical Review: Opiate Addiction and Opioid Receptors , 2018, Cell transplantation.

[7]  P. W. Czoty,et al.  A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates , 2018, Science Translational Medicine.

[8]  B. Kieffer,et al.  Opioid receptors: drivers to addiction? , 2018, Nature Reviews Neuroscience.

[9]  M. Bennett,et al.  Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review , 2018, BMJ Supportive & Palliative Care.

[10]  M. Liechti,et al.  Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome , 2018, British journal of pharmacology.

[11]  S. Park,et al.  Opioid rotation versus combination for cancer patients with chronic uncontrolled pain: a randomized study , 2015, BMC Palliative Care.

[12]  E. Kalso,et al.  Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat , 2015, British journal of pharmacology.

[13]  S. Mercadante.  Efficacy and safety of dual opioid therapy , 2014, Expert opinion on drug safety.

[14]  D. Harris.  Management of pain in advanced disease. , 2014, British medical bulletin.

[15]  A. Yoshitake,et al.  [Opioid combination of transdermal fentanyl and oral oxycodone for pain in a patient with giant-cell tumor of the sacrum]. , 2014, Masui. The Japanese journal of anesthesiology.

[16]  G. Mion,et al.  Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings) , 2013, CNS neuroscience & therapeutics.

[17]  V. Shah,et al.  Postoperative analgesia with epidural opioids after cesarean section: Comparison of sufentanil, morphine and sufentanil-morphine combination , 2012, Journal of anaesthesiology, clinical pharmacology.

[18]  L. Webster.  Efficacy and safety of dual-opioid therapy in acute pain. , 2012, Pain medicine.

[19]  J. Whistler,et al.  Chronic Methadone Treatment Shows a Better Cost/Benefit Ratio than Chronic Morphine in Mice , 2012, Journal of Pharmacology and Experimental Therapeutics.

[20]  K. Brzeziński.  Opioid combination. Case report , 2011 .

[21]  B. Laird,et al.  A systematic review of combination step III opioid therapy in cancer pain: An EPCRC opioid guideline project , 2011, Palliative medicine.

[22]  D. Riff,et al.  Analgesic and adverse effects of a fixed-ratio morphine-oxycodone combination (MoxDuo) in the treatment of postoperative pain. , 2011, Journal of opioid management.

[23]  C. Foti,et al.  The Addition of Tramadol as a Second Opioid May Improve Pain Relief in Severe Osteoarthritis: A Prospective Study , 2010, Pain practice : the official journal of World Institute of Pain.

[24]  S. Charlton,et al.  μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization , 2010, Molecular Pharmacology.

[25]  Z. Chi,et al.  The role of κ-opioid receptor activation in mediating antinociception and addiction , 2010, Acta Pharmacologica Sinica.

[26]  A. Paladini,et al.  Improved Cancer Pain Treatment Using Combined Fentanyl‐TTS and Tramadol , 2007, Pain practice : the official journal of World Institute of Pain.

[27]  N. Hara,et al.  Enhancement of Morphine Analgesic Effect with Induction of &mgr;-Opioid Receptor Endocytosis in Rats , 2006, Anesthesiology.

[28]  Graeme Henderson,et al.  75 years of opioid research: the exciting but vain quest for the Holy Grail , 2006, British journal of pharmacology.

[29]  Takuya Shinjo,et al.  [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report]. , 2005, Gan to kagaku ryoho. Cancer & chemotherapy.

[30]  M. Maltoni,et al.  A validation study of the WHO analgesic ladder: a two-step vs three-step strategy , 2005, Supportive Care in Cancer.

[31]  S. Mercadante,et al.  Addition of a second opioid may improve opioid response in cancer pain: preliminary data , 2004, Supportive Care in Cancer.

[32]  S. Mercadante.  Opioid combination for cancer pain , 2004, British Journal of Cancer.

[33]  G. Lauretti,et al.  Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients , 2003, British Journal of Cancer.

[34]  Hiroshi Baba,et al.  The Role of N-Methyl-d-Aspartate (NMDA) Receptors in Pain: A Review , 2003, Anesthesia and analgesia.

[35]  A. B. Thomsen,et al.  Opioid rotation in chronic non‐malignant pain patients , 1999, Acta anaesthesiologica Scandinavica.

[36]  E. Kalso,et al.  Controlled-release oxycodone and morphine in cancer related pain , 1997, Pain.

[37]  K. Elliott,et al.  Ketamine Attenuates and Reverses Morphine Tolerance in Rodents , 1996, Anesthesiology.

[38]  A. Jadad,et al.  The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. , 1995, JAMA.

[39]  M. E. Lewis,et al.  Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.

[40]  J. McDonald,et al.  Opioid Receptors , 2015, Methods in Molecular Biology.

[41]  M. Waldhoer,et al.  Opioid receptors. , 2004, Annual review of biochemistry.

[42]  M. Narita,et al.  Regulations of opioid dependence by opioid receptor types. , 2001, Pharmacology & therapeutics.